Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Genentech, Inc. (NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about Genentech, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 Next >
Genentech Announces Vice President Appointments in Commercial Operations and Manufacturing
October 05, 2006
from PR Newswire
New England Journal of Medicine Publishes Data From Lucentis Pivotal Phase III Studies in Wet Age-Related Macular Degeneration
October 05, 2006
Up to 40% of Patients Treated With LUCENTIS Improved Vision by Three Lines or More on the Study Eye Chart Read More
from PR Newswire
Genentech and CGI Pharmaceuticals Enter Into Exclusive Global Strategic Alliance for Potential Products in Multiple Oncology and Autoimmune Indications
October 04, 2006
from PR Newswire
FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
September 30, 2006
- Rituxan Improves Progression-Free Survival When Used in Combination with CVP Chemotherapy as a First-Line Treatment in Patients with Follicular Non- Hodgkin's Lymphoma - Read More
from PR Newswire
Seven Summits Research Releases Alerts on DNA, GM, MRVL, TSO, and ESV
September 28, 2006
from PR Newswire
Genentech Announces October 10 Webcast Discussion of Third Quarter Earnings and Other Business Results
September 20, 2006
from PR Newswire
Investment Tips for Aggressive Traders! September 13, 2006
September 13, 2006
EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts. Read More
from Marketwired News Releases
ERUG Is Still on the Move: Announces the Release of Its 2005 Financials! September 12, 2006
September 12, 2006
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. Read More
from Marketwired News Releases
Genentech Receives Complete Response Letter From FDA for Avastin(R) in Metastatic Breast Cancer
September 11, 2006
from PR Newswire
Top Stock Newsletter Positive Every Month of 2006
September 07, 2006
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by BullTrade.com. Read More
from Marketwired News Releases
BaroFold Grants Protein Technology Research License to Genentech
September 07, 2006
from Business Wire News Releases
Internet's Foremost Newsletter Hits Positive Territory for the 22nd Month in a Row
September 04, 2006
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by BullTrade.com. Read More
from Marketwired News Releases
Genentech and Biogen Idec Announce Positive Results From a Phase II Trial of Rituxan in Relapsing-Remitting Multiple Sclerosis
August 28, 2006
from PR Newswire
Genentech Foundation for Biomedical Sciences Awards $1.2 Million to Health Science Education Programs in the Bay Area
August 18, 2006
from PR Newswire
Genentech Provides Update on Supplemental Biologics License Application for Adjuvant Herceptin(R) in Early-Stage HER2-Positive Breast Cancer
August 12, 2006
from PR Newswire
XOMA Reports Second Quarter 2006 Results
August 09, 2006
from Business Wire News Releases
Genizon BioSciences Licenses Crohn's Disease GeneMap to Genentech; Results of Whole Genome Association Study to Be Used to Support Development of New Therapeutics and Diagnostics
August 08, 2006
from Business Wire News Releases
SmallCap Sentinel: The Ever-Increasing Applications for Non-Controversial Adult Stem Cells
August 07, 2006
from GlobeNewswire News Releases
Genentech Announces Vice President and Officer Appointments in Product Development and Finance
July 27, 2006
from PR Newswire
Genentech & Inotek Enter into Exclusive Global Strategic Alliance for the Discovery, Development and Commercialization of PARP Inhibitors for Cancer
July 25, 2006
from PR Newswire
Stock Traders Applaud "Stock Alerts" as Portfolio Values Rise
July 18, 2006
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by BullTrade.com. Read More
from Marketwired News Releases
California Healthcare Institute Launches Innovative Web Site for California's Life Sciences Industry
July 18, 2006
from Business Wire News Releases
Schaeffer's Upon Further Review Highlights the Following Stocks: Dynamic Materials, Genentech, Genzyme, Ruby Tuesday, and Travelzoo
July 12, 2006
from Business Wire News Releases
Investment Tips for Aggressive Traders! July 12, 2006
July 12, 2006
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts. Read More
from Marketwired News Releases
Seven Summits Research Releases Alerts on MO, DNA, HES, CC, and RI
July 12, 2006
from PR Newswire
California Healthcare Institute to Launch Innovative Web Site for California's Life Sciences Industry
July 12, 2006
from Business Wire News Releases
XOMA to Receive New Royalty Stream From Bacterial Production License; LUCENTIS(TM) is First Approved Drug Licensed Under XOMA's BCE Program
July 12, 2006
from Business Wire News Releases
Genentech Announces Second Quarter 2006 Results
July 11, 2006
- Quarterly Revenues Surpass $2 Billion - Read More
from PR Newswire
Schaeffer's Announces Posture Changes for Allstate, Chesapeake, Genentech, Pepsico, St Jude Medical
June 30, 2006
from Business Wire News Releases
FDA Approves LUCENTIS for the Treatment of Wet Age-Related Macular Degeneration
June 30, 2006
Up to 40% of Patients Treated With LUCENTIS in Pivotal Studies Gained at Least Three Lines of Vision on the Study Eye Chart at One Year Read More
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here